Steven Schell - 30 Dec 2021 Form 4/A - Amendment Insider Report for Heliogen, Inc. (HLGN)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4/A - Amendment
Accepted by SEC
07 Jan 2022, 20:36:48 UTC
Original report date
05 Jan 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Dorothy Vinsky, Attorney-in-Fact

Key filing fact

Steven Schell filed Form 4/A - Amendment for Heliogen, Inc. (HLGN) on 07 Jan 2022.

Key facts

  • This page summarizes Steven Schell's Form 4/A - Amendment filing for Heliogen, Inc. (HLGN).
  • 4 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 07 Jan 2022, 20:36.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HLGN transaction

Common Stock

Award

Transaction value
$0
Shares
+150,996
Change %
Price
$0.000000
Shares after
150,996
Date
30 Dec 2021
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

HLGN transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+1,509,964
Change %
Price
$0.000000
Shares after
1,509,964
Date
30 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,509,964
Exercise price
$0.1800
Footnotes
F2, F3
HLGN transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+1,006,643
Change %
Price
$0.000000
Shares after
1,006,643
Date
30 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,006,643
Exercise price
$0.0900
Footnotes
F3, F4
HLGN transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
$0
Shares
+201,328
Change %
Price
$0.000000
Shares after
201,328
Date
30 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
201,328
Exercise price
$0.0900
Footnotes
F3, F5
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

These shares are represented by restricted stock units ("RSUs") issued by Heliogen, Inc., a Delaware corporation ("Legacy Heliogen") and assumed by the Issuer on December 30, 2021 pursuant to that certain Business Combination Agreement ("Merger Agreement"), dated as of July 6, 2021, by and among Athena Technology Acquisition Corp., a Delaware corporation ("Athena"), HelioMax Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Athena, and Legacy Heliogen. Each RSU represents a contingent right to receive one share of the Common Stock of the Issuer. Six and one-quarter percent (6.25%) of the shares underlying the RSUs vest in quarterly installments with the first installment vesting on March 15, 2022, subject to the Reporting Person's continuous service.

Footnote F2

The shares shall vest in 48 equal monthly installments commencing on July 22, 2020, subject to the Reporting Person's continuous service.

Footnote F3

Represents options issued by Legacy Heliogen and assumed by the Issuer on December 30, 2021 pursuant to the Merger Agreement.

Footnote F4

One quarter (25%) of the shares vested on February 6, 2020, and the remainder of the shares shall vest in 36 equal monthly installments, subject to the Reporting Person's continuous service.

Footnote F5

The shares shall vest in 48 equal monthly installments commencing on December 6, 2018, subject to the Reporting Person's continuous service.

SEC remarks

The original Form 4, filed on January 5, 2022, is being amended by this Form 4/A to correct the previously reported exercise price of the stock options. The number of shares underlying the stock options previously reported correctly accounted for the Exchange Ratio (as defined in the Merger Agreement). The exercise price for the stock options has now also been adjusted to reflect the Exchange Ratio.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .